PELICCI, PIER GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 38
EU - Europa 32
NA - Nord America 9
Totale 79
Nazione #
SG - Singapore 24
IT - Italia 13
CN - Cina 12
US - Stati Uniti d'America 9
RU - Federazione Russa 7
SE - Svezia 4
FI - Finlandia 3
DE - Germania 2
SA - Arabia Saudita 2
FR - Francia 1
LV - Lettonia 1
NL - Olanda 1
Totale 79
Città #
Singapore 22
Shanghai 10
Pisa 4
Helsinki 3
Boardman 2
Copertino 2
Los Angeles 2
Moscow 2
Riyadh 2
Turin 2
Amsterdam 1
Ashburn 1
Frankfurt am Main 1
Hamm 1
Jiaxing 1
Lawrence 1
Miami 1
Milan 1
Princeton 1
Riga 1
Xi'an 1
Totale 62
Nome #
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses 14
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 14
RNAi screens identify CHD4 as an essential gene in breast cancer growth 13
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion 12
In Vivo genetic screens of patient-derived tumors revealed unexpected frailty of the transformed phenotype 11
Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth 11
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells 9
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value 8
Development of personalized therapeutic strategies by targeting actionable vulnerabilities in metastatic and chemotherapy-resistant breast cancer pdxs 8
Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation 7
UNCAN.eu: Toward a European Federated Cancer Research Data Hub 1
Totale 108
Categoria #
all - tutte 1.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 2 2 0 0 0 1 0 1 0 0 0 0
2023/202460 0 0 0 0 1 0 0 0 0 1 0 58
2024/202541 21 1 1 17 1 0 0 0 0 0 0 0
Totale 108